Optimization of pre-ESRD care: The key to improved dialysis outcomes

Kidney International

Volumn 57, Issue 1, 2000, Pages 351-365

  Pereira, B J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Dialysis; ESRD costs and outcomes; Osteodystrophy; Renal replacement therapy

Indexed keywords

SERUM ALBUMIN;

ADULT; CASE REPORT; EARLY DIAGNOSIS; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; MALNUTRITION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; UREMIA;

EID: 0034051407     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00840.x     Document Type: Article

References (92)

1. U.S. Renal Data System USRDS 1999 Annual Data Report 1999 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda
2. U.S. Renal Data System USRDS 1997 Annual Data Report 1997 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda
3. U.S. Renal Data System USRDS 1998 Annual Data Report 1998 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda
4. W.F. Owen N.L. Lew Y. Liu E.G. Lowrie J.M. Lazarus The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis N Engl J Med 329 1993 1001 1006
5. W.F. Keane A.J. Collins Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis Am J Kidney Dis 24 1994 1010 1018
6. Nih Consensus Statement Morbidity and mortality of dialysis Ann Intern Med 121 1994 62 70
7. C. Jones G. McQuillan J. Kusek M. Eberhardt W. Herman J. Coresh M. Salive C. Jones L. Agadoa Serum creatinine levels in the U.S. population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 32 1998 992 999
8. Health Care Financing Administration 1994 ESRD Core Indicators Project initial results: Opportunities to improve care for adult in-center hemodialysis patients 1994 Department of Health and Human Services, Health Care Financing Administration, Health Standards and Quality Bureau Baltimore
9. NKF-DOQI Clinical practice guidelines for peritoneal dialysis adequacy Am J Kidney Dis 30 Suppl 2 1997 S67 S136
10. G.T. Obrador P. Arora A. Kausz B.J.G. Pereira Pre-ESRD care in the United States: A state of disrepair J Am Soc Nephrol 9 1998 544 554
11. L.G. Hunsicker S. Adler A. Caggiula B.K. England T. Green J.W. Kusek N.L. Rogers P.E. Teschan the Modification of Diet in Renal Disease Study Group Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 1997 1908 1919
12. E.J. Lewis L.G. Hunsicker R.P. Bain R.D. Rohde Collaborative Study Group The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
13. I. Giatras J. Lau A.S. Levey Effect of angiotensin-converting-enzyme inhibitors on the progression of non-diabetic renal disease: A meta-analysis of randomized trials Ann Intern Med 127 1997 337 345
14. L.M.B. Laffel J.B. McGill D. Gans on behalf of the Northern American Microalbuminuria Study Group The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria Am J Med 99 1995 497 504
15. J.C. Peterson S. Adler J.M. Burkart T. Greene L.A. Hebert L.G. Hunsicker A.J. King S. Klahr S.G. Massry J.L. Seifter Blood pressure, proteinuria, and the progression of renal disease: The Modification of Diet in Renal Disease Study Ann Intern Med 123 1995 754 762
16. The Sixth Report of the Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure 1997 National Institutes of Health, National Heart, Lung, and Blood Institute Bethesda 47 48
17. H.R. Jacobson G.E. Striker Report of a workshop to develop management recommendations for the prevention of progression in chronic renal failure Am J Kidney Dis 25 1995 103 106
18. J.M. Lazarus J.J. Bourgoignie V.M. Buckalew T. Greene A.S. Levey N.C. Milas L. Parandini J.C. Peterson J.G. Porush S. Rauch J.M. Soucie C. Stollar Modification of Diet in Renal Disease Study Group Achievement and safety of a low blood pressure goal in chronic renal disease Hypertension 29 1997 641 650
19. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
20. The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial Kidney Int 47 1995 1703 1720
21. S. Klahr A.S. Levey G.J. Beck A.W. Caggiula L. Hunsicker J.W. Kusek G. Striker Modification of Diet in Renal Disease Study Group The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease N Engl J Med 330 1994 877 884
22. S. Klahr Is there still a role for a diet very low in protein, with or without supplements, in the management of patients with end-stage renal disease? Curr Opin Nephrol Hypertens 5 1996 384 387
23. A.S. Levey S. Adler A.W. Caggiula B.K. England T. Greene L.G. Hunsicker J.W. Kusek N.L. Rogers P.E. Teschan Modification of Diet in Renal Disease Study Group Effects of dietary protein restriction on the progression of advanced renal disease in the MDRD Study Am J Kidney Dis 27 1996 652 663
24. M.T. Pedrini A.S. Levey J. Lau T.C. Chalmers P.H. Wang The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: A meta-analysis Ann Intern Med 124 1996 627 632
25. W.M. McClellan D.F. Knight H. Karp W.W. Brown Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practiced and published guidelines Am J Kidney Dis 29 1997 368 375
26. S. Kenny P. Smith M. Goldschmid J. Newman W. Herman Survey of physician practice behaviors related to diabetes mellitus in the U.S. Diabetes Care 16 1993 1507 1510
27. F. Port Morbidity and mortality in dialysis patients Kidney Int 46 1994 1728 1737
28. F.X. McCusker B.P. Teehan K.E. Thorpe P.R. Keshaviah D.N. Churchill Canada-USA (CANUSA) Peritoneal Dialysis Study Group How much peritoneal dialysis is required for the maintenance of a good nutritional state? Kidney Int 50 Suppl 56 1996 S56 S61
29. E.G. Lowrie L.N. Lew Death risk in hemodialysis patients: The predictive value of commonly used measured variables and an evaluation of death rate differences between facilities Am J Kidney Dis 5 1990 458 482
30. D. Churchill D. Taylor R. Cook P. Laplante P. Barre P. Cartier W. Fay M. Goldstein K. Jindal H. Mandin Canadian hemodialysis morbidity study Am J Kidney Dis 19 1992 214 234
31. R.M. Hakim N. Levin Malnutrition in hemodialysis patients Am J Kidney Dis 21 1993 125 137
32. G.T. Obrador B.J.G. Pereira Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure Am J Kidney Dis 31 1998 398 417
33. W.F. Owen E.G. Lowrie C-reactive protein as an outcome predictor for maintenance hemodialysis patients Kidney Int 54 1998 627 636
34. J. Bergström B. Lindholm Malnutrition, cardiac disease, and mortality: An integrated point of view Am J Kidney Dis 32 1998 834 841
35. United States Renal Data System Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients Am J Kidney Dis 20 Suppl 2 1992 32 38
36. G.T. Obrador R. Ruthazer P. Arora A. Kausz B.J.G. Pereira Prevalence of and factors associated with sub-optimal care prior to initiation of dialysis in the United States J Am Soc Nephrol 10 1999 1793 1800
37. P. Arora G. Obrador R. Ruthazer A. Kausz K. Meyer C. Jenuleson B.J.G. Pereira Prevalence, predictors and consequences of late nephrology referral at a tertiary care center J Am Soc Nephrol 6 1999 1281 1286
38. W.E. Mitch Dietary protein restriction in patients with chronic renal failure Kidney Int 40 1991 326 341
39. R. Foley A. Levey M. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal failure Am J Kidney Dis 32 Suppl 3 1998 S112 S119
40. A. Levin J. Singer C.R. Thompson H. Ross M. Lewis Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention Am J Kidney Dis 27 1996 347 354
41. R.N. Foley P.S. Parfrey J.D. Harnett G.M. Kent C.J. Martin D.C. Murray P.E. Barre Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
42. R.N. Foley P.S. Parfrey J.D. Harnett G.M. Kent D.C. Murray P.E. Barre The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
43. J. Portoles A. Torralbo P. Martin J. Rodrigo J. Herrero A. Barrientos Cardiovascular effects of recombinant human erythropoietin in predialysis patients Am J Kidney Dis 29 1997 541 548
44. J.W. Eschbach T. Aquiling N.R. Haley M.H. Fan C.R. Blagg The long-term effects of recombinant human erythropoietin on the cardiovascular system Clin Nephrol 38 1992 S98 S103
45. NKF-DOQI Clinical practice guidelines for the treatment of anemia of chronic renal failure Am J Kidney Dis 30 Suppl 3 1997 S192 S240
46. A. Schwartz J. Prior G. Mintz K. Kim S. Kahn Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant human erythropoietin Transplant Proc 23 1991 1827 1830
47. Anonymous Effectiveness and safety of recombinant human erythropoietin in predialysis patients: Austrian Multicenter Study Group of r-HuEPO in predialysis patients Nephron 61 1992 399 403
48. N. Powe R. Griffiths A. Watson G. Anderson G. de Lissovoy J. Greer R. Herbert R. Milam P. Whelton Effect of recombinant human erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients J Am Soc Nephrol 4 1994 1455 1465
49. D.J. Sherrard G. Hercz Y. Pei N.A. Maloney C. Greenwood A. Manuel C. Siphoo S.S. Fenton G.V. Segre The spectrum of bone disease in end-stage renal failure—An evolving disorder Kidney Int 43 1993 436 442
50. D. Bushinsky The contribution of acidosis to renal osteodystrophy Kidney Int 47 1995 1816 1832
51. 2D Kidney Int 27 1985 565 573
52. I. Martinez R. Saracho J. Montenegro F. Llach The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure Am J Kidney Dis 29 1997 496 502
53. G. Coen S. Mazzaferro P. Ballant D. Sardella S. Chicca M. Manni E. Bonucci F. Taggi Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study Nephrol Dial Transplant 11 1996 813 819
54. E. Slatopolsky N.S. Bricker The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease Kidney Int 4 1993 141 145
55. E. Slatopolsky J. Finch M. Denda C. Ritter M. Zhong A. Dusso P.N. MacDonald Phosphorus restriction prevents parathyroid gland growth J Clin Invest 97 1996 2534 2540
56. C. Christiansen P. Rodbro M.S. Christensen B. Hartnack I. Transbol Deterioration of renal function during treatment of chronic renal failure with 1-25 vit D Lancet 2 1978 700 703
57. A. Torres V. Lorenzo D. Hernandez J.C. Rodriguez A.M. Concepcion A.P. Rodriguez A. Hernandez E. deBonis E. Darias J.M. Gonzales-Posada M. Losada M. Rufino A.J. Felsenfeld M. Rodriguez Bone disease in pre-dialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH Kidney Int 47 1995 1434 1442
58. M. Wang G. Hercz D.J. Sherrard N.A. Maloney G.V. Segre Y. Pei Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity Am J Kidney Dis 26 1995 836 844
59. J.D. Harnett R.N. Foley G.M. Kent P.E. Barre D. Murray P.S. Parfrey Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors Kidney Int 47 1995 884 890
60. J.S. Silberberg P.E. Barre S.S. Prichard A.D. Sniderman Impact of left ventricular hypertrophy on survival in end-stage renal disease Kidney Int 36 1989 286 290
61. B. Tucker F. Fabbian M. Giles R.C. Thuraisingham A.E. Raine L.R. Baker Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure Nephrol Dial Transplant 12 1997 724 728
62. Annual Report 1998. Don Mills, Ontario: 1998 Dialysis and Transplantation, Canadian Organ Replacement Register, Canadian Institute for Health Information Ottawa
63. A. Disney G. Russ R. Walker A.E. Sheil ANZDATA Report 1998 1996 Australia and New Zealand Dialysis and Transplant Registry Adelaide
64. W. Bloembergen Cardiac disease in chronic uremia: Epidemiology Adv Ren Replace Ther 4 1997 185 193
65. P.W. Wilson Established risk factors and coronary artery disease: The Framingham study Am J Hypertens 7 1994 7S 12S
66. F. Vendemia A. Forniasieri O. Velis M. Baroni B. Scarduelli G. D'amico Different prevalence rates of hypertension in various reno-parenchymal diseases, Secondary Forms of Hypertension: Current Diagnosis and Management edited by Balufox MD, Bianchi C 1990 Raven New York 1583 1599
67. V.M. Buckalew R.L. Berg S.-R. Wang J.G. Porush S. Rauch G. Schulman Prevalence of hypertension in 1,795 subjects with chronic renal disease: The Modification of Diet in Renal Disease Study cohort Am J Kidney Dis 28 1996 811 821
68. R.N. Foley P.S. Parfrey Cardiac disease in chronic uremia: Clinical outcomes and risk factors Adv Ren Replace Ther 4 1997 234 248
69. A. Bostom L. Lathrop Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology and potential relationship to arteriosclerotic outcomes Kidney Int 52 1997 10 20
70. National Kidney Foundation Task Force on Cardiovascular Disease Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32 Suppl 1998 S1 S199
71. P.J. Ratcliffe R.E. Phillips D.O. Oliver Late referral for maintenance dialysis Br Med J 288 1984 441 443
72. S. Rasgon L. Schwankovsky A. James-Rogers L. Widrow J. Glick E. Butts An intervention for employment maintenance among blue-collar workers with end-stage renal disease Am J Kidney Dis 22 1993 403 412
73. NKF-DOQI Clinical Practice Guidelines for Vascular Access Am J Kidney Dis 30 Suppl 3 1997 S150 S191
74. J.D. Woods M.N. Turenne R.L. Strawderman E.W. Young R.A. Hirth F.K. Port P.J. Held Vascular access survival among incident hemodialysis patients in the United States Am J Kidney Dis 30 1997 50 57
75. S.J. Schwab Vascular access for hemodialysis Kidney Int 55 1999 2078 2090
76. U.S. Renal Data System USRDS 1995 Annual Data Report 1995 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda
77. F. Schillinger D. Schillinger R. Montagnac T. Milcent Post-catheterization vein stenosis in haemodialysis patients: Comparative angiographic study of 50 subclavian and 50 internal jugular accesses Nephrol Dial Transplant 6 1991 722 724
78. P.J. Held F.K. Port R.A. Wolfe D.C. Stannard C.E. Carrol J.T. Daugirdas W.E. Bloembergen J.W. Greer R.M. Hakim The dose of hemodialysis and patient mortality Kidney Int 50 1996 550 556
79. A.J. Bleyer M.V. Rocco J.M. Burkart The cost of hospitalizations due to hemodialysis access management Nephrol News Issues 9 1995 19 22
80. S.A. Hood B. Schillo E. Beane V. Rozas J.H. Sondheimer Members of the Michigan Renal Plan Task Force of the Michigan Public Health Institute An analysis of the adequacy of preparation for end-stage renal disease care in Michigan ASAIO J 41 1995 M422 M426
81. J. Tattersall R. Greenwood K. Farrington Urea kinetics and when to commence dialysis Am J Nephrol 15 1995 283 289
82. V. Bonomini A. Albertazzi A. Vangelista G.C. Bortolotti S. Stefoni M.P. Scolari Residual renal function and effective rehabilitation in chronic dialysis Nephron 16 1976 89 99
83. V. Bonomini C. Feletti M.P. Scolari S. Stefoni Benefits of early initiation of dialysis Kidney Int 28 1985 S57 S59
84. D.N. Churchill D.W. Taylor P.R. Keshaviah the Canada USA (CANUSA) Peritoneal Dialysis Study Group Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes J Am Soc Nephrol 7 1996 198 207
85. W.J. Johnson S.B. Kurtz J.C.I. Mitchell C.J. Van Den Berg Results of treatment of center hemodialysis patients Mayo Clin Proc 59 1984 669 671
86. J.M. Malangone J.G. Abuelo J.C. Pezzullo K. Lund C.A. McGloin Clinical and laboratory features of patients with chronic renal disease at the start of dialysis Clin Nephrol 31 1989 77 87
87. A. Levey J. Bosch J. Lewis T. Greene N. Rogers D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation Ann Intern Med 130 1999 461 470
88. Obrador G, Arora P, Kausz A, Ruthazer R, Pereira B, Levey A: Level of renal function at initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int (in press)
89. W.E. Bloembergen F.K. Port E.A. Mauger R.A. Wolfe A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis J Am Soc Nephrol 6 1995 177 183
90. J. Jollis E. Delong E. Peterson L. Muhlbaier D. Fortin R. Califf D. Mark Outcome of acute myocardial infarction according to the specialty of the admitting physician N Engl J Med 335 1996 1880 1887
91. T. Schreiber A. Elkhatib C. Grines W. O'neill Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes J Am Coll Cardiol 26 1995 577 582 10.1016/0735-1097(95)00214-o
92. S. Laidlaw R. Berg J. Kopple H. Naito W. Walker M. Walser Modification of Diet in Renal Disease Study Group Patterns of fasting plasma amino acid levels in chronic renal insufficiency: Results from the feasibility phase of the modification of diet in renal disease study Am J Kidney Dis 23 1993 504 513